4//SEC Filing
Sagent Pharmaceuticals, Inc. 4
Accession 0001562180-16-001732
CIK 0001369786operating
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 12:41 PM ET
Size
4.8 KB
Accession
0001562180-16-001732
Insider Transaction Report
Form 4
Drake Lorin
VP, Sales and Marketing
Transactions
- Tax Payment
Common Stock
2016-02-18$15.16/sh−452$6,852→ 32,077 total
Documents
Issuer
Sagent Pharmaceuticals, Inc.
CIK 0001369786
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001369786
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 12:41 PM ET
- Size
- 4.8 KB